Algorithms for Ligand based Virtual Screening in Drug Discovery

被引:0
|
作者
Babaria, Khushboo [1 ]
Das, Shubhankar [1 ]
Ambegaokar, Sanya [1 ]
Palivela, Hemant [1 ]
机构
[1] NMIMS, MPSTME, IT Dept, Bombay, Maharashtra, India
关键词
SVM; Kernel;
D O I
暂无
中图分类号
TP301 [理论、方法];
学科分类号
081202 ;
摘要
Machine learning can play a very important role in various crucial applications like data mining and pattern recognition. Machine learning techniques have been widely used in drug discovery and development, particularly in the areas of chemo-informatics, bioinformatics and other types of pharmaceutical research. It has been demonstrated that they are suitable for large high dimensional data, and the models built with these methods can be used for robust external predictions. This paper discusses on how the machine learning techniques, especially Support Vector Machines, are going to be applied on the data sets with the help of graph kernels. These graph kernels are used to compare substructures of graphs that are computable in polynomial time.
引用
收藏
页码:862 / 866
页数:5
相关论文
共 50 条
  • [31] Virtual screening of chemical libraries for drug discovery
    Green, Darren V. S.
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (09) : 1011 - 1026
  • [32] Recent advances in virtual screening for drug discovery
    Leung, Chung-Hang
    Ma, Dik-Lung
    METHODS, 2015, 71 : 1 - 3
  • [33] Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents
    Costa, Fernanda C.
    Nicoluci, Ricardo P.
    Silva, Marcio
    Rocha, Waldireny C.
    Vieira, Paulo C.
    Oliva, Glaucius
    Thiemann, Otavio H.
    Andricopulo, Adriano D.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (03) : 158 - 161
  • [34] Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques
    Noha, Stefan M.
    Atanasov, Atanas G.
    Schuster, Daniela
    Markt, Patrick
    Fakhrudin, Nanang
    Heiss, Elke H.
    Schrammel, Olivia
    Rollinger, Judith M.
    Stuppner, Hermann
    Dirsch, Verena M.
    Wolber, Gerhard
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 577 - 583
  • [35] Ligand- and Structure-based Virtual Screening Studies for the Discovery of Selective Inhibitors
    Park, Jung Woo
    Hong, Sung-Wha
    2019 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2019, : 1235 - 1236
  • [36] Integration of Ligand- and Target-Based Virtual Screening for the Discovery of Cruzain Inhibitors
    Wiggers, H. J.
    Rocha, J. R.
    Cheleski, J.
    Montanari, C. A.
    MOLECULAR INFORMATICS, 2011, 30 (6-7) : 565 - 578
  • [37] Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
    Matthias Rupp
    T Schroeter
    R Steri
    Ewgenij Proschak
    K Hansen
    H Zettl
    O Rau
    M Schubert-Zsilavecz
    K-R Müller
    Gisbert Schneider
    Journal of Cheminformatics, 2 (Suppl 1)
  • [38] Emerging Approaches to GPCR Ligand Screening for Drug Discovery
    Kumari, Punita
    Ghosh, Eshan
    Shukla, Arun K.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (11) : 687 - 701
  • [39] Virtual Screening Strategies in Drug Discovery: A Critical Review
    Lavecchia, A.
    Di Giovanni, C.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (23) : 2839 - 2860
  • [40] The compromise of virtual screening and its impact on drug discovery
    Slater, Olivia
    Kontoyianni, Maria
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (07) : 619 - 637